Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Zhengrong Li
Northwestern Polytechnic University (NPU) - Institute of Medical Research
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
38
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Erzhi Pill Protects Against Hepatic Ischemia/Reperfusion Injury Through Activating PI3K/Akt/SIRT1 Signaling Pathway
Number of pages: 29
Posted: 11 Apr 2023
Wangting Li
,
Haixia Chen
, Zhengrong Li,
Dongmei Hu
,
Yuwen Liu
,
Shaojie Huang
,
Sijun Hu
,
Jinyi Chen
,
Xingru Tao
,
Yue Chen
,
Fei Mu
,
Jialin Duan
and
Jingwen Wang
Government of the People's Republic of China - Xijing Hospital, Government of the People's Republic of China - Xijing Hospital, Northwestern Polytechnic University (NPU) - Institute of Medical Research, Government of the People's Republic of China - Xijing Hospital, Northwestern Polytechnic University (NPU) - Institute of Medical Research, Government of the People's Republic of China - Xijing Hospital, Northwestern Polytechnic University (NPU) - Institute of Medical Research, Government of the People's Republic of China - Xijing Hospital, Government of the People's Republic of China - Xijing Hospital, Government of the People's Republic of China - Xijing Hospital, Government of the People's Republic of China - Xijing Hospital, Northwestern Polytechnic University (NPU) - Institute of Medical Research and Government of the People's Republic of China - Xijing Hospital
Downloads
38
(1,209,354)
View PDF
Download
Abstract:
Erzhi pill, hepatic ischemia-reperfusion injury, PI3K/AKT, SIRT1.
Feedback
